Search Results

Baxter Publishes 2019 Corporate Responsibility Report, Highlighting Efforts to Make a Meaningful Difference as a Leading Global Corporate Citizen

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today released its 2019 Corporate Responsibility Report.

Celebrating an Influential Woman in Manufacturing

Confidence is key in a successful career

Creating a Digital Imprint Around the World

R&D director shares his passion for digital healthcare and diversity

Baxter Highlights New Data on the Role Technologies Play in Improving Care for Dialysis Patients During the 57th ERA-EDTA Virtual Congress

Baxter International Inc. (NYSE:BAX), a global innovator in renal care, today announced new data showing use of Baxter’s Sharesource remote patient management (telehealth) platform for automated peritoneal dialysis (APD) therapy performed in Colombia was associated with a 56% reduction in technique failure.

Baxter Senior Leadership Team Commitment to Addressing Racial Injustice

Our focus on Inclusion & Diversity (I&D) at Baxter has never been more compelling or urgent. Racism has been a longstanding and disturbing societal issue, and recent displays of racial injustice toward the Black community have rocked U.S. society to its core – with the impact resonating far beyond. The events are all the worse for playing out against a pandemic that’s compounding health and economic disparities globally.

Baxter to Present at the Goldman Sachs 41st Annual Global Healthcare Conference Webcast

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Goldman Sachs 41st Annual Global Healthcare Conference Webcast on Tuesday, June 9, 2020. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 9:40 a.m. Eastern Time.  The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through June 9, 2021.

Man on a Mission

Army veteran feels at home working at Baxter

Engineer Embraces New Challenges

"Take every opportunity you are given"

Baxter Receives CE Marking and Australian Regulatory Approval for Evo IQ Syringe Infusion System, Building on Smart Pump Platform

Baxter International Inc. (NYSE:BAX), a leader in innovative technology for medication delivery, today announced CE marking and regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for the Evo IQ Syringe Infusion System. The company expects hospitals in the United Kingdom, Ireland, Greece, Australia and New Zealand to be among the first to receive the new system, with additional countries to follow in a series of planned regulatory submissions.

Understanding Continuous Renal Replacement Therapy (CRRT) in COVID-19 Management

COVID-19 is affecting patients in many yet-to-be-understood ways. One of its unexpected impacts? Acute kidney injury (AKI), which is sudden kidney failure usually due to infection or trauma. During AKI, the kidneys stop working and fluid and uremic toxins build up in the body.